Claritev Corporation, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company is headquartered in New York, New York.
| Revenue (TTM) | $978.76M |
| Gross Profit (TTM) | $716.71M |
| EBITDA | $533.34M |
| Operating Margin | 7.55% |
| Return on Equity | -646.00% |
| Return on Assets | 1.10% |
| Revenue/Share (TTM) | $59.18 |
| Book Value | $-14.18 |
| Price-to-Book | 43.86 |
| Price-to-Sales (TTM) | 0.38 |
| EV/Revenue | 5.19 |
| EV/EBITDA | 10.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 5.80% |
| Shares Outstanding | $17.05M |
| Float | $5.79M |
| % Insiders | 7.44% |
| % Institutions | 90.95% |